imidazoquinoline
Small moleculeexperimental
Clinical trial activity
3 trials · 25 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
2
Phase 4
0
Earliest trial started Nov 25, 2020 (NCT04641481)
Timeline
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05258669 | Phase 2/Phase 3 (Phase 3) | Feb 20, 2022 | Ocugen |
| NCT04641481 | Phase 3 | Nov 25, 2020 | Aligarh Muslim University, All India Institute of Medical Sciences, Baba Raghav Das Medical Gorakhpur, Bharat Biotech International Limited, ESIC Medical College and Hospital Faridabad, Gauhati Medical College & Hospital Assam, Gmers Medical College and Civil Hospital,Ahmedabad, Government of India, Grant Government Medical College & Sir J J Group of Hospitals, Guntur Medical College ,Guntur, Guru Tej Bahadur Hospital, Kanpur India, Indian Council of Medical Research, Institute of Post Graduate Medical Education & Research, IQVIA, King George Hospital Visakhapatnam, Lokmanya Tilak Municipal Medical College, Mahatma Gandhi Medical College, Nizam's Institute of Medical Sciences, Hyderabad, India, Peoples University, Bhanpur, Bhopal, Prince Aly Khan Hospital Mumbai, Rahate Surgical Hospital ,Nagpur, Redkar Hospital and Research Centre Goa, Vagus Super speciality hospital,Bangalore, Vydehi Institute of Medical Sciences and Research Centre,Bangalore |
| NCT05541289 | N/A | — | Ocugen |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (25)
25 organizations
Page 1 / 2